Form 4: Director Robert S. White Acquires AtriCure Shares

Director Robert S. White acquired 6,144 shares of AtriCure, Inc. common stock through a Restricted Stock Award.

Summary

• Robert S. White, a Director at AtriCure, Inc., acquired 6,144 shares of common stock on May 18, 2026.
• The acquisition was made through a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan.
• These shares are subject to vesting upon the one-year anniversary of the grant date.
• Following this transaction, Mr. White beneficially owns 128,318 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard stock award to a director rather than an open market purchase or sale.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition is part of a formal stock incentive plan, indicating a structured approach to employee and director compensation.

Future Outlook

The acquired shares will vest upon the one-year anniversary of the grant date, indicating a future event tied to continued service or performance.

Industry Context

StockSavvy.ai notes that insider stock awards are a common practice in the medical device industry to align management and director interests with those of shareholders and to attract and retain talent.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively as a sign of commitment, but it does not represent a new investment from external capital.

Next Steps

• Vesting of the acquired shares upon the one-year anniversary of the grant date.

Key Dates

Keywords

AtriCure, ATRC, Form 4, Insider Trading, Stock Award, Director, Beneficial Ownership, Securities Exchange Act